SCYNEXIS, Inc. Operating Leases, Rent Expense
SCYNEXIS, Inc. (SCYX) reported Operating Leases, Rent Expense of $294.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2017-03-13
- SCYNEXIS, Inc. operating leases, rent expense for the quarter ending 2015-12-31 was -$275.00K.
- SCYNEXIS, Inc. operating leases, rent expense for the quarter ending 2015-09-30 was $86.00K, a 63.40% decline year-over-year.
- SCYNEXIS, Inc. operating leases, rent expense for the quarter ending 2015-06-30 was $219.00K, a 7.20% decline year-over-year.
- SCYNEXIS, Inc. operating leases, rent expense for the quarter ending 2015-03-31 was $218.00K, a 5.63% decline year-over-year.
- SCYNEXIS, Inc. operating leases, rent expense for fiscal 2016 was $294.00K, a 19.03% increase from fiscal 2015.
- SCYNEXIS, Inc. operating leases, rent expense for fiscal 2015 was $247.00K, a 97.60% increase from fiscal 2014.
- SCYNEXIS, Inc. operating leases, rent expense for fiscal 2014 was $125.00K.
| Period end | Operating Leases, Rent Expense 3 month | Operating Leases, Rent Expense 6 month | Operating Leases, Rent Expense 9 month | Operating Leases, Rent Expense 12 month | Operating Leases, Rent Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2016-12-31 | $294.00K 10-K · filed 2017-03-13 | ||||
| 2015-12-31 | -$275.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | -$189.00K derived: sum of 2 quarters · filed 2017-03-13 | $30.00K derived: sum of 3 quarters · filed 2017-03-13 | $247.00K 10-K · filed 2017-03-13 | $641.00K 10-K · filed 2016-03-07 |
| 2015-09-30 | $86.00K 10-Q · filed 2015-11-13 | $305.00K derived: sum of 2 quarters · filed 2015-11-13 | $522.00K 10-Q · filed 2015-11-13 | -$54.00K derived: sum of 4 quarters · filed 2017-03-13 | |
| 2015-06-30 | $219.00K 10-Q · filed 2015-08-19 | $437.00K 10-Q · filed 2015-08-19 | -$140.00K derived: sum of 3 quarters · filed 2017-03-13 | $95.00K derived: sum of 4 quarters · filed 2017-03-13 | |
| 2015-03-31 | $218.00K 8-K · filed 2015-10-30 | -$359.00K derived: sum of 2 quarters · filed 2017-03-13 | -$124.00K derived: sum of 3 quarters · filed 2017-03-13 | $112.00K derived: sum of 4 quarters · filed 2017-03-13 | |
| 2014-12-31 | -$577.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | -$342.00K derived: sum of 2 quarters · filed 2017-03-13 | -$106.00K derived: sum of 3 quarters · filed 2017-03-13 | $125.00K 10-K · filed 2017-03-13 | $952.00K 10-K · filed 2015-03-30 |
| 2014-09-30 | $235.00K 10-Q · filed 2015-11-13 | $471.00K derived: sum of 2 quarters · filed 2015-11-13 | $702.00K 10-Q · filed 2015-11-13 | $921.00K derived: sum of 4 quarters · filed 2015-11-13 | |
| 2014-06-30 | $236.00K 10-Q · filed 2015-08-19 | $467.00K 10-Q · filed 2015-08-19 | $686.00K derived: sum of 3 quarters · filed 2015-10-30 | $923.00K derived: sum of 4 quarters · filed 2015-10-30 | |
| 2014-03-31 | $231.00K 8-K · filed 2015-10-30 | $450.00K derived: sum of 2 quarters · filed 2015-10-30 | $687.00K derived: sum of 3 quarters · filed 2015-10-30 | $914.00K derived: sum of 4 quarters · filed 2015-10-30 | |
| 2013-12-31 | $219.00K derived: 8-K 12 month − 10-Q 9 month · filed 2015-10-30 | $456.00K derived: sum of 2 quarters · filed 2015-10-30 | $683.00K derived: sum of 3 quarters · filed 2015-10-30 | $906.00K 8-K · filed 2015-10-30 | |
| 2013-09-30 | $237.00K 10-Q · filed 2014-11-13 | $464.00K derived: sum of 2 quarters · filed 2014-11-13 | $687.00K 10-Q · filed 2014-11-13 | ||
| 2013-06-30 | $227.00K 10-Q · filed 2014-08-13 | $450.00K 10-Q · filed 2014-08-13 | |||
| 2013-03-31 | $223.00K 10-Q/A · filed 2014-07-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |